Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleCorrection: Zheng et al. Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy. Cancers 2022, 14 , 5344.AuthorsZheng, Haosheng; Long, Guojie; Zheng, Yuzhen; Yang, Xingping; Cai, Weijie; He, Shiyun; Qin, Xianyu; Liao, HongyingSubjectsTUMOR markers; GLYCOLYSISPublicationCancers, 2023, Vol 15, Issue 3, p586ISSN2072-6694Publication typeCorrection NoticeDOI10.3390/cancers15030586